EHJ Editor-in-Chief/X
Aug 7, 2025, 05:52
Early Heparin in STEMI Care? EHJ Publishes Results of the Groundbreaking HELP-PCI Trial
EHJ Editor-in-Chief (Filippo Crea) posted on X:
”Could administering heparin at first medical contact improve outcomes in STEMI treatment? Read the results of HELP-PCI trial in EHJ.”
Read the full article here.
The HELP-PCI trial studied 999 STEMI patients undergoing PPCI to compare the timing of UFH administration—at first medical contact (FMC) vs in the Cath Lab.
Patients who received UFH at FMC had significantly better initial coronary blood flow (TFG-3: 23.6% vs 17.6%; OR 1.44; P = .02).
No differences were seen in 12-month MACCE, reperfusion success, or major bleeding.
Early UFH may improve pre-PPCI perfusion without added risk.
Stay updated on the latest scientific advances with Hemostasis Today.
-
May 28, 2026, 05:29Kidist K.: First Balloon Pulmonary Angioplasty Performed as New CTEPH Program Launches
-
May 28, 2026, 04:59Maria Sol Andres: Exploring Lipid Disorders in Modern Cancer Care
-
May 28, 2026, 04:42Francesca Granata: Representing the Porphyria Community at the 79th World Health Assembly
-
May 28, 2026, 04:29Samone Cook: When Collaboration Turns Into Organizational Coagulation
-
May 28, 2026, 03:42Lara Bloom: 15,000 Steps, Countless Conversations – One Unforgettable WHA79
-
May 27, 2026, 23:00Octavio Marques Pontes-Neto: Exchanging Latin American Experiences at the Global Stroke Alliance Meeting in Buenos Aires
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?